dm+d

31009911000001106

Articles

Assigning stability to Zerbaxa (ceftolozane/tazobactam) in elastomeric infusers

16 November 2022Assessment of the degradation profile and toxicity data for Zerbaxa is available for its use in Outpatient Parenteral Antimicrobial Therapy (OPAT) services
Search Articles

Refrigerated Storage

Zerbaxa Merck Sharp & Dohme Limited

Merck Sharp & Dohme Limited
Zerbaxa
Concentrate for solution for infusion, 1g/0.5g

Contact MSD in all cases where a deviation from the recommended storage conditions has occurred. Refer to the electronic medicines compendium (eMC) at https://www.medicines.org.uk for company contact details.

21 February 2022
London MI Service